---
figid: PMC2666844__gcr1_4ap0013f4
figlink: /pmc/articles/PMC2666844/figure/f4-gcr1_4ap0013/
number: F4
caption: Simplified schematic diagram of insulin-like growth factor (IGF) signaling.
  IGF-I and IGF-II bind to IGF receptor (IGFR), a receptor tyrosine kinase (RTK),
  with high affinity resulting in phosphorylation of intracellular proteins including
  insulin receptor substrate (IRS). The signal is then conveyed to specific downstream
  effectors such as phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT/PKB),
  and mitogen-activated protein kinase (MAPK) pathways. These pathways play crucial
  roles in antiapoptosis as well as cell proliferation. Bioavailability of both IGFs
  is influenced by the presence of IGF binding proteins (IGFBP). New therapeutic agents
  such as AG1024 and gefitinib aim to block this signaling pathway at level of the
  receptor. Downstream targeting agents such as rapamycin, CCI-779, and RAD001 are
  also under investigation.
pmcid: PMC2666844
papertitle: Liver Stem Cells and Molecular Signaling Pathways in Hepatocellular Carcinoma.
reftext: Krit Kitisin, et al. Gastrointest Cancer Res. 2007 Jul-Aug;1(4 Suppl 2):S13-S21.
pmc_ranked_result_index: '101298'
pathway_score: 0.9446333
filename: gcr1_4ap0013f4.jpg
figtitle: Simplified schematic diagram of insulin-like growth factor (IGF) signaling
year: '2007'
organisms: Homo sapiens
ndex: 38949d6b-defc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2666844__gcr1_4ap0013f4.html
  '@type': Dataset
  description: Simplified schematic diagram of insulin-like growth factor (IGF) signaling.
    IGF-I and IGF-II bind to IGF receptor (IGFR), a receptor tyrosine kinase (RTK),
    with high affinity resulting in phosphorylation of intracellular proteins including
    insulin receptor substrate (IRS). The signal is then conveyed to specific downstream
    effectors such as phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT/PKB),
    and mitogen-activated protein kinase (MAPK) pathways. These pathways play crucial
    roles in antiapoptosis as well as cell proliferation. Bioavailability of both
    IGFs is influenced by the presence of IGF binding proteins (IGFBP). New therapeutic
    agents such as AG1024 and gefitinib aim to block this signaling pathway at level
    of the receptor. Downstream targeting agents such as rapamycin, CCI-779, and RAD001
    are also under investigation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGFBP5
  - MAPK11
  - AKT2
  - IRS4
  - IRS1
  - AKT1
  - MAPK8
  - IGF1
  - IGF2
  - IGFBP2
  - IGFBP3
  - MAPK1
  - MAPK12
  - AKT3
  - IGFBP7
  - MAPK13
  - IGFBP4
  - MAPK9
  - IGFBP1
  - IGF1R
  - MAPK10
  - IGFBP6
  - IRS2
  - MAPK3
  - MAPK14
  - Rapamycin
genes:
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP5
  entrez: '3488'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGF-II
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP2
  entrez: '3485'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP3
  entrez: '3486'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP7
  entrez: '3490'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP4
  entrez: '3487'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP1
  entrez: '3484'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP6
  entrez: '3489'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC2666844__F4
redirect_from: /figures/PMC2666844__F4
figtype: Figure
---
